Genmab A/S (GMAB)
Genmab A/S Statistics
Share Statistics
Genmab A/S has 635.5M shares outstanding. The number of shares has increased by -2.3% in one year.
| Shares Outstanding | 635.5M |
| Shares Change (YoY) | -2.3% |
| Shares Change (QoQ) | 0.21% |
| Owned by Institutions (%) | 93.68% |
| Shares Floating | 635.49M |
| Failed to Deliver (FTD) Shares | 193 |
| FTD / Avg. Volume | 0.01% |
Short Selling Information
The latest short interest is 2.31M, so 0.36% of the outstanding shares have been sold short.
| Short Interest | 2.31M |
| Short % of Shares Out | 0.36% |
| Short % of Float | 0.36% |
| Short Ratio (days to cover) | 1.96 |
Valuation Ratios
The PE ratio is 12.39 and the forward PE ratio is 1.51. Genmab A/S's PEG ratio is 0.15.
| PE Ratio | 12.39 |
| Forward PE | 1.51 |
| PS Ratio | 4.51 |
| Forward PS | 0.3 |
| PB Ratio | 2.65 |
| P/FCF Ratio | 12.81 |
| PEG Ratio | 0.15 |
Enterprise Valuation
Genmab A/S has an Enterprise Value (EV) of 887.03M.
| EV / Sales | 0.04 |
| EV / EBITDA | 0.12 |
| EV / EBIT | 0.11 |
| EV / FCF | 0.12 |
Financial Position
The company has a current ratio of 5.25, with a Debt / Equity ratio of 0.03.
| Current Ratio | 5.25 |
| Quick Ratio | 5.24 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.14 |
| Debt / FCF | 0.14 |
| Interest Coverage | 55.86 |
Financial Efficiency
Return on Equity is 21.38% and Return on Invested Capital is 14.13%.
| Return on Equity | 21.38% |
| Return on Assets | 17.12% |
| Return on Invested Capital | 14.13% |
| Revenue Per Employee | $8.03M |
| Profits Per Employee | $2.92M |
| Employee Count | 2,682 |
| Asset Turnover | 0.47 |
| Inventory Turnover | 15.89 |
Taxes
| Income Tax | 1.32B |
| Effective Tax Rate | 14.4% |
Stock Price Statistics
The stock price has increased by -33.71% in the last 52 weeks. The beta is 0.96, so Genmab A/S's price volatility has been higher than the market average.
| Beta | 0.96 |
| 52-Week Price Change | -33.71% |
| 50-Day Moving Average | 20.47 |
| 200-Day Moving Average | 23.06 |
| Relative Strength Index (RSI) | 48.12 |
| Average Volume (20 Days) | 1.65M |
Income Statement
In the last 12 months, Genmab A/S had revenue of 21.53B and earned 7.84B in profits. Earnings per share was 121.36.
| Revenue | 21.53B |
| Gross Profit | 20.54B |
| Operating Income | 6.7B |
| Net Income | 7.84B |
| EBITDA | 7.39B |
| EBIT | 7.08B |
| Earnings Per Share (EPS) | 121.36 |
Balance Sheet
The company has 9.86B in cash and 1.03B in debt, giving a net cash position of 8.83B.
| Cash & Cash Equivalents | 9.86B |
| Total Debt | 1.03B |
| Net Cash | 8.83B |
| Retained Earnings | 23.55B |
| Total Assets | 45.81B |
| Working Capital | 22.55B |
Cash Flow
In the last 12 months, operating cash flow was 7.77B and capital expenditures -187M, giving a free cash flow of 7.58B.
| Operating Cash Flow | 7.77B |
| Capital Expenditures | -187M |
| Free Cash Flow | 7.58B |
| FCF Per Share | 117.34 |
Margins
Gross margin is 95.42%, with operating and profit margins of 31.14% and 36.44%.
| Gross Margin | 95.42% |
| Operating Margin | 31.14% |
| Pretax Margin | 42.57% |
| Profit Margin | 36.44% |
| EBITDA Margin | 34.33% |
| EBIT Margin | 31.14% |
| FCF Margin | 35.23% |
Dividends & Yields
GMAB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 8.07% |
| FCF Yield | 78.06% |
Analyst Forecast
The average price target for GMAB is $41, which is 110.1% higher than the current price. The consensus rating is "Buy".
| Price Target | $41 |
| Price Target Difference | 110.1% |
| Analyst Consensus | Buy |
| Analyst Count | 9 |
Stock Splits
The last stock split was on May 1, 2018. It was a forward split with a ratio of 5:1.
| Last Split Date | May 1, 2018 |
| Split Type | forward |
| Split Ratio | 5:1 |
Scores
| Altman Z-Score | 3.06 |
| Piotroski F-Score | 5 |